<html>
<head>
  <title>2C8</title>
<style>
  .td {font-family: "verdana"; font-size: "10px"; color: "navy";}
  .green {background-color:"#ACA899";font-family:verdana; font-size:8pt;}
  .lite {background-color:"#F1EFE2";font-family:verdana; font-size:8pt; color:"#666600";}
  A:link {COLOR: "navy"; text-decoration: none;}
  A:visited {COLOR: "navy"; text-decoration: none;}
  A:active {COLOR: "navy"; text-decoration: none;}
  A:hover {COLOR:"#66CCFF";}
</style>
</head>

<body bgcolor="#FFFFFF">
<CENTER>
	<TABLE class="green" border="0" cellPadding="5" cellSpacing="1" width="600">

	
	<tr class="lite"><td>
	<b>References for Cytochrome P450 Drug Interaction Table</b><br>
	Part 3 of 8: 2C8 Isoform<br><br>
	

These pages contain all the literature citations referenced in the Cytochrome P450 Drug Interaction Tables (both the extensive <a HREF="index.htm">research-oriented table</a> and the concise <a HREF="clinlist.htm"> clinical table</a>). Most of these citations are hyperlinks, which bring up the abstract in the NLM's <i>PubMed<sup>®</sup></i> database.
	
<p>
Click on the <font COLOR="Blue"><i><u>PubMed</u></i></font> link after the drug name to perform a live MedLINE search of articles possibly related to that drug and
Cytochrome P450.</p>

<p>
Entries are organized by mode of activity (substrate, inhibitor, inducer)
within specific isoform. You can quickly branch to a section by clicking
on the appropriate link here:
</p>

<center>
  <table ALIGN="Center" cellpadding="5" cellspacing="1" border="0">
    <tr>
      <td class="td"><p ALIGN="Right">1A2:</td>
      <td class="td"><a HREF="1A2.htm#1A2sub">Substrates</a></td>
      <td class="td"><a HREF="1A2.htm#1A2inh">Inhibitors</a></td>
      <td class="td"><a HREF="1A2.htm#1A2ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2B6:</td>
      <td class="td"><a HREF="2B6.htm#2B6sub">Substrates</a></td>
      <td class="td"><a HREF="2B6.htm#2B6inh">Inhibitors</a></td>
      <td class="td"><a HREF="2B6.htm#2B6ind">Inducers</a></td>
      </tr>
	  
    <tr>
      <td class="td"><p ALIGN="Right">2C8:</td>
      <td class="td"><a HREF="2C8.htm#2C8sub">Substrates</a></td>
      <td class="td"><a HREF="2C8.htm#2C8inh">Inhibitors</a></td>
      <td class="td"><a HREF="2C8.htm#2C8ind">Inducers</a></td>
      </tr>

    <tr>
      <td class="td"><p ALIGN="Right">2C19:</td>
      <td class="td"><a HREF="2C19.htm#2C19sub">Substrates</a></td>
      <td class="td"><a HREF="2C19.htm#2C19inh">Inhibitors</a></td>
      <td class="td"><a HREF="2C19.htm#2C19ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2C9:</td>
      <td class="td"><a HREF="2C9.htm#2C9sub">Substrates</a></td>
      <td class="td"><a HREF="2C9.htm#2C9inh">Inhibitors</a></td>
      <td class="td"><a HREF="2C9.htm#2C9ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2D6:</td>
      <td class="td"><a HREF="2D6.htm#2D6sub">Substrates</a></td>
      <td class="td"><a HREF="2D6.htm#2D6inh">Inhibitors</a></td>
      <td class="td"><a HREF="2D6.htm#2D6ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">2E1:</td>
      <td class="td"><a HREF="2E1.htm#2E1sub">Substrates</a></td>
      <td class="td"><a HREF="2E1.htm#2E1inh">Inhibitors</a></td>
      <td class="td"><a HREF="2E1.htm#2E1ind">Inducers</a></td>
    </tr>
    <tr>
      <td class="td"><p ALIGN="Right">3A4,5,7:</td>
      <td class="td"><a HREF="3A457.htm#3A457sub">Substrates</a></td>
      <td class="td"><a HREF="3A457.htm#3A457inh">Inhibitors</a></td>
      <td class="td"><a HREF="3A457.htm#3A457ind">Inducers</a></td>
    </tr>
  </table>
  </center>

<p>
Hint: a quick way to find a specific reference on this page is to use your web browser's Search feature: press Ctrl-F and type all or part of the name or word for which you are searching.</p>
<p>
  <hr>

  <a NAME="2C8sub"><img src="2C8substrates.jpg"></a>

<p>
   <a name="amodiaquine"><b>amodiaquine</b></a>: <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+amodiaquine&doptcmdl=DocSum">PubMed</a>
</p>
<p>
   <i>Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.</i><br>
   Li XQ, Bjorkman A, Andersson TB, Ridderstrom M, Masimirembwa CM.<br>
   <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11805197&dopt=Abstract">J Pharmacol Exp Ther. 2002 Feb;300(2):399-407.</a>
</p>

<p>
   <a name="cerivastatin"><b>cerivastatin</b></a>: <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+cerivastatin&doptcmdl=DocSum">PubMed</a>
</p>
<p>
   <i>Clinical pharmacokinetics of cerivastatin.</i><br>
   Muck W.<br>
   <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10976657&dopt=Abstract">Clin Pharmacokinet. 2000 Aug;39(2):99-116.</a><br><br>
   <i>Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes.</i><br>
   Wang JS, Neuvonen M, Wen X, Backman JT, Neuvonen PJ.<br>
   <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12433802&dopt=Abstract">Drug Metab Dispos. 2002 Dec;30(12):1352-6.</a>
</p>


<p>
   <a NAME="paclitaxel"><b>paclitaxel</b></a>: <i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+paclitaxel&doptcmdl=DocSum">PubMed</a></i>
</p>
<p>
   <i>Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants.</i><br>
   Vaclavikova R, Horsky S, Simek P, Gut I.<br>
   <a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12920504&dopt=Abstract">Naunyn Schmiedebergs Arch Pharmacol. 2003 Sep;368(3):200-9. Epub 2003 Aug 14.</a>
</p>



<p>
   <a NAME="repaglinide"><b>repaglinide</b></a>: <i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+repaglinide&doptcmdl=DocSum">PubMed</a></i>
</p>
<p>
   <i>CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.</i><br>
   Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT.<br>
   <a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12919179&dopt=Abstract">Br J Clin Pharmacol. 2003 Sep;56(3):305-14.</a><br><br>
   
   <i>Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide.</i><br>
   Niemi M, Leathart JB, Neuvonen M, Backman JT, Daly AK, Neuvonen PJ.<br>
   <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14534525&dopt=Abstract">Clin Pharmacol Ther. 2003 Oct;74(4):380-7.</a>
</p>

<p>
   <a NAME="rosiglitazone"><b>rosiglitazone</b></a>: <i><a HREF="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+rosiglitazone&doptcmdl=DocSum">PubMed</a></i>
</p>
<p>
<i>Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.</i><br>
Baldwin SJ, Clarke SE, Chenery RJ.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10510156&dopt=Abstract">Br J Clin Pharmacol. 1999 Sep;48(3):424-32.</a>
</p>

<p>
   <a name="torsemide"><b>torsemide</b></a>: <i><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+torsemide&doptcmdl=DocSum">PubMed</a></i>
</p>
<p>
<i>The xenobiotic inhibitor profile of cytochrome P4502C8.</i><br>
Ong CE, Coulter S, Birkett DJ, Bhasker CR, Miners JO.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11136296&dopt=Abstract">Br J Clin Pharmacol. 2000 Dec;50(6):573-80.</a>
</p>

<a NAME="2C8inh"><img src="2C8inhibitors.jpg"></a>

<p>
   <a name="gemfibrozil"><b>gemfibrozil</b></a>: <i><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+gemfibrozil&doptcmdl=DocSum">PubMed</a></i>
</p>
<p>
<i>Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes.</i><br>
Wang JS, Neuvonen M, Wen X, Backman JT, Neuvonen PJ.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12433802&dopt=Abstract">Drug Metab Dispos. 2002 Dec;30(12):1352-6.</a><br><br>

<i>Gemfibrozil greatly increases plasma concentrations of cerivastatin.</i><br>
Backman JT, Kyrklund C, Neuvonen M, Neuvonen PJ.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12496749&dopt=Abstract">Clin Pharmacol Ther. 2002 Dec;72(6):685-91.</a><br><br>

<i>Gemfibrozil considerably increases the plasma concentrations of rosiglitazone.</i><br>
Niemi M, Backman JT, Granfors M, Laitila J, Neuvonen M, Neuvonen PJ.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12898007&dopt=Abstract">Diabetologia. 2003 Oct;46(10):1319-23. Epub 2003 Jul 29.</a>
</p>

<p>
   <a name="glitazones"><b>glitazones (thiazolidinediones)</b></a>: <i><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+thiazolidinediones&doptcmdl=DocSum">PubMed</a></i>
</p>
<p>
<i>Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.</i><br>
Sahi J, Black CB, Hamilton GA, Zheng X, Jolley S, Rose KA, Gilbert D, LeCluyse EL, Sinz MW.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12642470&dopt=Abstract">Drug Metab Dispos. 2003 Apr;31(4):439-46.</a>
</p>

<p>
   <a name="quercetin"><b>quercetin</b></a>: <i><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+quercetin&doptcmdl=DocSum">PubMed</a></i>
</p>
<p>
<i>Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids.</i><br>
Marill J, Capron CC, Idres N, Chabot GG.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11911845&dopt=Abstract">Biochem Pharmacol. 2002 Mar 1;63(5):933-43.</a>
</p>

<p>
   <a name="trimethoprim"><b>trimethoprim</b></a>: <i><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+trimethoprim&doptcmdl=DocSum">PubMed</a></i>
</p>
<p>
<i>Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively.</i><br>
Wen X, Wang JS, Backman JT, Laitila J, Neuvonen PJ.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12019187&dopt=Abstract">Drug Metab Dispos. 2002 Jun;30(6):631-5.</a>
</p>

<a NAME="2C8ind"><img src="2C8inducers.jpg"></a>

<p>
   <a name="rifampin"><b>rifampin</b></a>: <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dispmax=20&db=PubMed&pmfilter_EDatLimit=No+Limit&cmd_current=Limits&orig_db=PubMed&cmd=Search&term=cytochrome+AND+p450+AND+rifampin&doptcmdl=DocSum"><i>PubMed</i></a>
</p>
<p>
<i>Expression and Induction of CYP2C P450 Enzymes in Primary Cultures of Human Hepatocytes</i><br>
Raucy JL, Mueller L, Duan K, Allen SW, Strom S, Lasker JM.<br>
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12130704&dopt=Abstract">J Pharmacol Exp Ther. 2002 Aug;302(2):475-82.</a>
</p>
</body>
</html>
